(Los Angeles, CA, Tuesday, June 2, 2020) – The Alzheimer’s Association estimates that 5.8 million Americans age 65 and older are currently living with Alzheimer’s, and this number is projected to increase to more than seven million by 2025.
The Alzheimer Prevention Trials (APT) Webstudy provides people with the opportunity to participate in Alzheimer’s research from the comfort and safety of their own home. Researchers monitor participant’s brain health through regular online memory testing and then matches them to clinical trials they might consider.
The APT Webstudy is free to join for healthy adults over the age of 50.
Funded by the National Institutes of Health, the study is led by internationally renowned researchers from the Alzheimer’s Therapeutic Research Institute of the Keck School of Medicine of USC, Brigham and Women’s Hospital, and the Cleveland Clinic.
Enrollees in this online study use the internet to help stop Alzheimer’s disease, while being alerted to changes in their own brain health.
While some drugs can slow the onset of Alzheimer’s disease, there is no cure. New treatments are urgently needed.
Because Alzheimer’s begins 15 to 20 years before the onset of symptoms, researchers need tens of thousands of volunteers who have little to no symptoms of the disease.
The APT Webstudy monitors participants through regular online memory testing, which they can do from the comfort and convenience of their own home or office. It then matches them to Alzheimer’s disease prevention trials that they might consider. The APT Webstudy does not require participants to take medication and is not a clinical trial itself; it’s an “observational” study, meaning researchers look at (or observe) changes over time in measures of memory function.